SPC100
Empagliflozin og sölt þar af, sér í lagi Empagliflozin
Status:
VeittApplication date:
3.10.2014Application published:
15.10.2014Grant published:
15.6.2015
Max expiry date:
26.11.2029Next due date:
31.3.2027Medicine name:
JardianceMedicine for children:
Yes
Timeline
Today
3.10.2014Application
15.10.2014Publication
15.6.2015Registration
10.3.2027Expires
Marketing license
IS authorization number:
EU/1/14/930/001-009 & 010-018Date:
5.6.2014
Foreign authorization number:
EU/1/14/930Date:
22.5.2014
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, Ingelheim DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1730131
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 20.2.2025
Expires: 10.3.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 2
Paid: 19.2.2026
Expires: 10.3.2027
Payer: G.H. Sigurgeirsson ehf.